Citation Impact
Citing Papers
RNA polymerase II trigger loop residues stabilize and position the incoming nucleotide triphosphate in transcription
2010 StandoutNobel
HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels
2003 StandoutNobel
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
De novo design of immunoglobulin-like domains
2022 StandoutNobel
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
2002
Structure and function of cellular deoxyribonucleoside kinases
2002
Mechanisms of type-I- and type-II-interferon-mediated signalling
2005 Standout
A Complex of the Srb8, -9, -10, and -11 Transcriptional Regulatory Proteins from Yeast
2002 StandoutNobel
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
2006 Standout
Histone acetylation and transcriptional regulatory mechanisms
1998 Standout
The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression
1998
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
A synthetic oscillatory network of transcriptional regulators
2000 StandoutNature
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
2007 StandoutNobel
Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs
2014
Differential Display Cloning of a Novel Human Histone Deacetylase (HDAC3) cDNA from PHA-Activated Immune Cells
1998
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
2001
Cellular Senescence in Cancer and Aging
2007 Standout
The Human Histone Deacetylase Family
2001
A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program
2001
Degradation of carboxy-terminal-tagged cytoplasmic proteins by the Escherichia coli protease HflB (FtsH)
1998
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
2003 StandoutNobel
Histone deacetylases, transcriptional control, and cancer
2000
Histone deacetylases: transcriptional repression with SINers and NuRDs
1999
Quantitation of the RNA Polymerase II Transcription Machinery in Yeast
2001 StandoutNobel
Histone deacetylases as regulators of inflammation and immunity
2011
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
The antioxidant function of the p53 tumor suppressor
2005
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Covalent modifications of histones: expression from chromatin templates
1998
ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis
2007 Standout
MAP kinase‐mediated phosphoacetylation of histone H3 and inducible gene regulation
2003
Histone deacetylases and cancer: causes and therapies
2001 Standout
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Robust enumeration of cell subsets from tissue expression profiles
2015 Standout
Functional Interaction between the Mouse Notch1 Intracellular Region and Histone Acetyltransferases PCAF and GCN5
2000 StandoutNobel
Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo
1998
p53 in health and disease
2007 Standout
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
2003 Standout
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
2007
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Histone acetylases and deacetylases in cell proliferation
1999
Regulation of type I interferon responses
2013 Standout
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
1998 StandoutNature
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
A Multiprotein Complex That Interacts with RNA Polymerase II Elongator
2001 StandoutNobel
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
2001 StandoutNobel
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress
2003 Standout
Histone Acetylation Modifiers in the Pathogenesis of Malignant Disease
2000
Systems-wide Proteomic Analysis in Mammalian Cells Reveals Conserved, Functional Protein Turnover
2011
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
2004 StandoutNobel
Epigenetic Regulation of Vascular Smooth Muscle Cell Proliferation and Neointima Formation by Histone Deacetylase Inhibition
2011
Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD
2005
Histone Acetyltransferases
2001 Standout
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Expression deconvolution: A reinterpretation of DNA microarray data reveals dynamic changes in cell populations
2003
Nanocell targeting using engineered bispecific antibodies
2014
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
2012 StandoutNobel
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The SWI/SNF Chromatin-Remodeling Factor Stimulates Repair by Human Excision Nuclease in the Mononucleosome Core Particle
2002 StandoutNobel
The Histone Acetylase PCAF Is a Phorbol-Ester-Inducible Coactivator of the IRF Family That Confers Enhanced Interferon Responsiveness
1999
Mechanisms of Diabetic Complications
2013 Standout
TRANSCRIPTION OF EUKARYOTIC PROTEIN-CODING GENES
2000
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
2007 StandoutNobel
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
TheCaenorhabditis elegansems class homeobox gene ceh-2 is required for M3 pharynx motoneuron function
2003 StandoutNobel
Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution
2001 StandoutScienceNobel
Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
1998 Nature
Association of the Mediator complex with enhancers of active genes
2003 StandoutNobel
RBP1 Recruits Both Histone Deacetylase-Dependent and -Independent Repression Activities to Retinoblastoma Family Proteins
1999 StandoutNobel
Works of Stefan Bartl being referenced
Molecular cloning and characterization of the mouse histone deacetylase 1 gene: integration of a retrovirus in 129SV mice
1999
Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties
2010
Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8
2000
Carboxy-terminal Residues of Mouse Thymidine Kinase are Essential for Rapid Degradation in Quiescent Cells
1996
Activation of the Mouse Histone Deacetylase 1 Gene by Cooperative Histone Phosphorylation and Acetylation
2002
Identification of Mouse Histone Deacetylase 1 as a Growth Factor-Inducible Gene
1997